A2 BIO Logo (WIPO, 06.04.2022)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke A2 BIO wurde als Bildmarke am 06.04.2022 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Quadrilateralen #Briefe, die eine besondere Form des Schreibens darstellen #Zahlen, die eine besondere Form der Schrift darstellen #Andere unregelmäßige Parallelogramme, Trapezien und Vierecke, Vierecke mit einer oder mehreren abgerundeten Ecken #Vierecke mit einer oder mehreren Ziffern #Quadrilaterale, die einen oder mehrere Buchstaben enthalten #Quadrilaterale mit dunklen Flächen oder Teilen von Flächen
| Markenform | Bildmarke |
| Aktenzeichen | 1687385 |
| Länder | 
|
| Basismarke |
Nr. 97074028,
14. Oktober 2021
|
| Anmeldedatum | 06. April 2022 |
| Ablaufdatum | 06. April 2032 |
Markeninhaber
30301 Agoura Road, Suite 210
Agoura Hills CA 91301
US
Agoura Hills CA 91301
US
Markenvertreter
411 Borel Avenue, Suite 603
San Mateo CA 94402
US
Waren und Dienstleistungen
05
Therapeutics in the nature of cells, proteins and protein
complexes for the treatment and prevention of cancer,
inflammation, and inflammatory diseases; biotherapeutics for
the treatment and prevention of cancer, inflammation, and
inflammatory diseases; medicines; pharmaceuticals;
pharmaceutical products for the treatment and prevention of
cancer and inflammatory diseases; therapeutic targets,
namely, cells, proteins and protein complexes, for the
treatment and prevention of cancer, inflammation and
inflammatory diseases; therapeutic cells, therapeutic
proteins and therapeutic antibodies for human use for the
treatment and prevention of cancer, inflammation and
inflammatory diseases; therapeutics and cell therapies in
the nature of cells, proteins and protein complexes for the
treatment of cancer, inflammation, and inflammatory
diseases; engineered cell therapies in the nature of cells,
proteins and protein complexes for medical purposes, namely,
the treatment and prevention of cancer, inflammation and
inflammatory diseases; engineered cell therapy platforms;
cell platforms for the treatment and prevention of cancer,
inflammation and inflammatory diseases; technology platforms
for developing and engineering therapeutic cells,
therapeutic proteins, therapeutic antibodies, therapeutics
and cellular therapies for the treatment and prevention of
cancer, inflammation, and inflammatory diseases; platform
for autologous and allogeneic cell manufacturing;
therapeutics and cell therapies in the nature of cells,
proteins and protein complexes targeting targets lost in
tumors for the treatment and prevention of cancer,
inflammation and inflammatory diseases; gene therapy
products, namely, genetically engineered tissues for
transplant purposes
40
Custom manufacturing of therapeutics, biotherapeutics,
medicines, and pharmaceuticals; manufacturing of cells,
therapeutics and cell therapies for the treatment and
prevention of cancer, inflammation and inflammatory
diseases; biomanufacturing for others; cell therapy
manufacturing for others; autologous and allogeneic cell
manufacturing for others; manufacturing services for others
in the fields of therapeutics, cell therapies, biologics,
medicine, and pharmaceuticals; providing technical
information in the field of pharmaceutical manufacturing;
custom manufacturing and engineering of biological cells,
cellular targets, proteins, and antibodies for others
42
Medical research services; pharmaceutical and
biopharmaceutical research and development services;
provision of information in the fields of therapeutics,
biotherapeutics, medicines, pharmaceuticals; provision of,
and identification and development of, therapeutic targets
for others for the treatment and prevention of cancer,
inflammation and inflammatory diseases; development of
therapeutics and cell therapies for treatment and prevention
of cancer, inflammation, and inflammatory diseases;
therapeutics and cell therapies targeting targets lost in
tumors for the treatment and prevention of cancer,
inflammation and inflammatory diseases; biotechnology
research, development, testing and analysis for the
treatment of cancer, inflammation, and inflammatory
diseases; scientific research and development services;
providing information relating to treatment and prevention
of cancer, inflammation and inflammatory diseases; research,
development, engineering and testing services in the fields
of therapeutics, cell therapies, biologics, medicine, and
pharmaceuticals; medical laboratory services, namely, tissue
material processing and analysis in the field of autologous
and allogeneic biologic preparations for medical use;
biotechnology laboratory services; scientific and medical
laboratory services; genetic engineering services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 03. August 2023 | 2023/31 Gaz | JP | Ablehnung |
| 07. März 2023 | 2023/12 Gaz | CN | Ablehnung |
| 28. Februar 2023 | 2023/9 Gaz | EM | Ablehnung |
| 28. Dezember 2022 | 2022/52 Gaz | GB | Ablehnung |
| 06. April 2022 | 2022/38 Gaz | US | Eintragung |
ID: 141687385